Early treatment of congenital and acquired hemophilia

This activity is older than 12 months.

These case studies have been developed with the assistance of Professor Robert Klamroth, MD, PhD, Head of the Department of Internal Medicine, Angiology and Coagulation Disorders, and Director of the Comprehensive Care Haemophilia Treatment Centre and the Haemostasis and Thrombosis Unit at the Vivantes Klinikum im Friedrichshain in Berlin, Germany. This activity was supported by Novo Nordisk Health Care AG.

The information is not intended as medical advice. Responsibility for patient care resides with the healthcare professional on the basis of his or her professional licence, experience and knowledge of the individual patient. For full prescribing information, including indications, contraindications, warnings, precautions and adverse events, please refer to the approved product labelling. Please note that products may have different product labelling according to geographical location.

All characters and events depicted in this patient case simulation are entirely fictitious. Any similarity to actual events or persons, living or dead, is purely coincidental. This activity is intended only for healthcare professionals registered to practice in Europe. To proceed, confirm that you are a healthcare professional residing in Europe.

Modules

• Early treatment of bleeds in congenital haemophilia with inhibitors

• Elderly patient with a complex case of acquired haemophilia A